Y0001832

Irinotecan -hydrochlorid Trihydrat

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): Irinotecan -monohydrochlorid Trihydrat, [1,4′-Bipiperidin]-1′-carbonsäure-(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]chinolin-9-yl-ester -monohydrochlorid Trihydrat
• Empirische Formel (Hill-System): C₃₃H₃₈N₄O₆ · HCl · 3H₂O
• CAS-Nummer: 136572-09-3
• Molekulargewicht: 677.18
• NACRES: NA.24

Eigenschaften

• Lagertemp.: 2-8°C
• InChI: 1S/C33H38N4O6.ClH.3H2O/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;;;;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H;3*1H2/t33-;;;;/m0..../s1
• InChIKey: KLEAIHJJLUAXIQ-JDRGBKBRSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Verpackung

Unit quantity: 170 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302
• P-Sätze: P301 + P312 + P330
• Gefahreneinstufungen: Acute Tox. 4 Oral
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable